Disease | hepatocellular carcinoma |
Phenotype | C0011847|diabetes |
Sentences | 14 |
PubMedID- 23173135 | This differential treatment time window between cases and controls likely led to the apparent increased risk of hepatocellular carcinoma with diet-controlled diabetes and consequently to an apparent decreased risk with metformin and thiazolidinediones. |
PubMedID- 23788857 | A man aged 56 years old, suffering from alcohol-induced cirrhosis, hypertension and insulin-treated type 2 diabetes was diagnosed with hepatocellular carcinoma (hcc) in early august 2008 on the basis of biopsy of the dominant tumorous lesion located in the right liver lobe. |
PubMedID- 20734163 | To clarify this point, we analyze the therapeutic effect of intra-arterial chemotherapy in unrespectable hepatocellular carcinoma patients with or without diabetes mellitus. |
PubMedID- 25641920 | Hyperglycemia is an important factor for chemoresistance of hepatocellular carcinoma patients with diabetes to therapeutics. |
PubMedID- 23236362 | Epidemiological studies highlight an increased prevalence of chronic liver disease and hepatocellular carcinoma in patients with type 2 diabetes [10], [12]. |
PubMedID- 21544812 | Increased risk of hepatocellular carcinoma in patients with diabetes mellitus: a systematic review and meta-analysis of cohort studies. |
PubMedID- 24386416 | diabetes mellitus is associated with hepatocellular carcinoma: a retrospective case-control study in hepatitis endemic area. |
PubMedID- 20559430 | This also provides biological plausibility into the increased risk of hepatocellular carcinoma in patients with diabetes according to cohort studies [50]. |
PubMedID- 23209929 | The elevated incidence of hepatocellular carcinoma in patients with diabetes could be related to the common association of diabetes with nonalcoholic fatty liver disease, and with viral hepatic disease, which are both risk factors for hepatic cancer [3]. |
PubMedID- 26252899 | This finding may help explain epidemiological studies from populations across the world that have reported a twofold to fourfold increase in risk of developing cirrhosis, liver failure and hepatocellular carcinoma in people with type 2 diabetes [1,6]. |
PubMedID- 20460909 | In addition, there is growing evidence linking obesity and type 2 diabetes with hepatocellular carcinoma in subjects with chronic viral hepatitis. |
PubMedID- 23244117 | Association of type ii diabetes mellitus with hepatocellular carcinoma occurrence--a case control study from kathmandu valley. |
PubMedID- 25117675 | Non-alcoholic steatohepatitis (nash) has emerged as a common cause of chronic liver disease and virus-independent hepatocellular carcinoma (hcc) in patients with obesity, diabetes, and metabolic syndrome. |
PubMedID- 23613635 | Increased international normalized ratio level in hepatocellular carcinoma patients with diabetes mellitus. |
Page: 1